MedPath

The effect of Alendronate on symptoms of knee osteoarthritis

Phase 3
Conditions
Knee osteoarthritis.
Gonarthrosis
Registration Number
IRCT138803271479N2
Lead Sponsor
Vice Chancellor for Research, Mashhad University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
39
Inclusion Criteria

fulfilling the American College of rheumatology (ACR) criteria of primary knee osteoarthritis, radiologically ascertained grade I or II severity of OA of the knee on the Kellgren-Lawrence scale, having a Western Ontario and McMaster Universities (WOMAC) pain subscale index of at least 2 at baseline (the 5-point Linkert version of the WOMAC), presence of daily knee pain for at least 6 months preceding the study
Exclusion criteria: Presence of secondary osteoarthritis, arthroscopy or surgery of target knee within 6 months prior to study, intra-articular treatment of target knee within 6 months prior to study, other chronic inflammatory processes, previous gastrointestinal problems (such as gastroesophageal reflux or esophageal stricture), previous allergic reactions to bisphosphonates, presence of any risk factors for osteoporosis

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in symptoms of knee osteoarthritis. Timepoint: Weeks 0, 4, 12, 24. Method of measurement: WOMAC Index.
Secondary Outcome Measures
NameTimeMethod
Joint space narrowing. Timepoint: weeks 0 and 24. Method of measurement: Knee X-ray.
© Copyright 2025. All Rights Reserved by MedPath